Hebert, A.; Schrieber, R.; Glaab, D.; Eichenfield, L. Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol Propionate Foam, 0.05% in Adolescent Subjects With Plaque Psoriasis. J of Skin 2020, 4, s77.